Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where CVS Health is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-08-17Current report (material event)
- SCHEDULE 13G/A2026-08-13SCHEDULE 13G/A
- 13F-HR2026-08-0613F-HR
- 10-Q2026-08-05Quarterly report
- 8-K2026-08-05Current report (material event)
- 11-K2026-06-2311-K
- S-82026-05-22Employee stock plan
- S-3ASR2026-05-22S-3ASR
- 8-K2026-05-18Current report (material event)
- 13F-HR2026-05-0713F-HR
- 10-Q2026-05-06Quarterly report
- 8-K2026-05-06Current report (material event)
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- ARS2026-04-03Annual report to holders
- DEFA14A2026-04-03DEFA14A
- DEF 14A2026-04-03Proxy statement
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- 8-K2026-03-19Current report (material event)
- 13F-HR2026-02-1313F-HR
- 10-K2026-02-10Annual report
- 8-K2026-02-10Current report (material event)
- 8-K2025-12-09Current report (material event)
- 8-K2025-11-20Current report (material event)
- 13F-HR2025-10-3113F-HR
- 10-Q2025-10-29Quarterly report
- 8-K2025-10-29Current report (material event)
- 8-K2025-09-22Current report (material event)
- 8-K2025-08-15Current report (material event)
- 424B22025-08-12424B2
- FWP2025-08-12FWP
- 424B32025-08-11424B3
- 13F-HR2025-08-0113F-HR
- 10-Q2025-07-31Quarterly report
- 8-K2025-07-31Current report (material event)
- SCHEDULE 13G/A2025-07-16SCHEDULE 13G/A
- 11-K2025-06-2611-K
- 8-K2025-05-20Current report (material event)
- SCHEDULE 13G2025-05-13SCHEDULE 13G
- 13F-HR2025-05-0213F-HR
- 10-Q2025-05-01Quarterly report
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.